Emergent Biosolutions Inc’s recently made public that its Director LOUIS W SULLIVAN acquired Company’s shares for reported $0.36 million on Jan 07 ’26. In the deal valued at $13.99 per share,25,748 shares were bought.
Then, LOUIS W SULLIVAN bought 104,695 shares, generating $1,336,463 in total proceeds.
Before that, Richard Ronald sold 21,984 shares. Emergent Biosolutions Inc shares valued at $263,077 were divested by the Director at a price of $11.97 per share. As a result of the transaction, Richard Ronald now holds 98,417 shares, worth roughly $1.2 million.
H.C. Wainwright initiated its Emergent Biosolutions Inc [EBS] rating to a Buy in a research note published on December 30, 2024; the price target was $15. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in late August with a ‘”a Buy”‘ rating. The Benchmark Company also remained covering EBS and has increased its forecast on March 07, 2024 with a “Buy” recommendation from previously “Hold” rating.
Price Performance Review of EBS
On Tuesday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock fall -1.78% to $12.17. Over the last five days, the stock has lost -7.45%. Emergent Biosolutions Inc shares have risen nearly 23.18% since the year began. Nevertheless, the stocks have fallen -1.54% over the past one year.
How much short interest is there in Emergent Biosolutions Inc?
A steep rise in short interest was recorded in Emergent Biosolutions Inc stocks on 2025-12-31, growing by 0.21 million shares to a total of 9.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 8.92 million shares. There was a rise of 2.27%, which implies that there is a positive sentiment for the stock.
